Taysha Gene Therapies
TSHA
#5807
Rank
HK$9.64 B
Marketcap
HK$29.57
Share price
-5.51%
Change (1 day)
-5.26%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2026 (TTM): -HK$3.37

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -HK$3.37. In 2022 the company made an earnings per share (EPS) of -HK$29.89 an increase over its 2021 EPS that were of -HK$36.32.

EPS history for Taysha Gene Therapies from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$3.37
2022-HK$29.89-17.71%
2021-HK$36.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.59 213.95%๐Ÿ‡บ๐Ÿ‡ธ USA